Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1974 2
1976 1
1997 4
1998 9
1999 9
2000 20
2001 21
2002 20
2003 46
2004 40
2005 44
2006 40
2007 39
2008 36
2009 43
2010 39
2011 46
2012 62
2013 68
2014 113
2015 134
2016 170
2017 166
2018 173
2019 201
2020 189
Text availability
Article attribute
Article type
Publication date

Search Results

1,557 results
Results by year
Filters applied: . Clear all
Page 1
Macrophages and Metabolism in the Tumor Microenvironment.
Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Vitale I, et al. Cell Metab. 2019 Jul 2;30(1):36-50. doi: 10.1016/j.cmet.2019.06.001. Cell Metab. 2019. PMID: 31269428 Free article. Review.
The Dual Roles of NRF2 in Cancer.
Menegon S, Columbano A, Giordano S. Menegon S, et al. Trends Mol Med. 2016 Jul;22(7):578-593. doi: 10.1016/j.molmed.2016.05.002. Epub 2016 Jun 2. Trends Mol Med. 2016. PMID: 27263465 Free article. Review.
PARP Inhibitors in Ovarian Cancer.
Mittica G, Ghisoni E, Giannone G, Genta S, Aglietta M, Sapino A, Valabrega G. Mittica G, et al. Recent Pat Anticancer Drug Discov. 2018;13(4):392-410. doi: 10.2174/1574892813666180305165256. Recent Pat Anticancer Drug Discov. 2018. PMID: 29512470 Review.
PDK1: At the crossroad of cancer signaling pathways.
Gagliardi PA, Puliafito A, Primo L. Gagliardi PA, et al. Semin Cancer Biol. 2018 Feb;48:27-35. doi: 10.1016/j.semcancer.2017.04.014. Epub 2017 May 1. Semin Cancer Biol. 2018. PMID: 28473254 Review.
How liquid biopsies can change clinical practice in oncology.
Siravegna G, Mussolin B, Venesio T, Marsoni S, Seoane J, Dive C, Papadopoulos N, Kopetz S, Corcoran RB, Siu LL, Bardelli A. Siravegna G, et al. Ann Oncol. 2019 Oct 1;30(10):1580-1590. doi: 10.1093/annonc/mdz227. Ann Oncol. 2019. PMID: 31373349 Review.
Liquid Biopsies, What We Do Not Know (Yet).
Bardelli A, Pantel K. Bardelli A, et al. Cancer Cell. 2017 Feb 13;31(2):172-179. doi: 10.1016/j.ccell.2017.01.002. Cancer Cell. 2017. PMID: 28196593 Free article. Review.
Exploiting DNA repair defects in colorectal cancer.
Reilly NM, Novara L, Di Nicolantonio F, Bardelli A. Reilly NM, et al. Mol Oncol. 2019 Apr;13(4):681-700. doi: 10.1002/1878-0261.12467. Epub 2019 Mar 2. Mol Oncol. 2019. PMID: 30714316 Free PMC article. Review.
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.
Sartore-Bianchi A, Trusolino L, Martino C, Bencardino K, Lonardi S, Bergamo F, Zagonel V, Leone F, Depetris I, Martinelli E, Troiani T, Ciardiello F, Racca P, Bertotti A, Siravegna G, Torri V, Amatu A, Ghezzi S, Marrapese G, Palmeri L, Valtorta E, Cassingena A, Lauricella C, Vanzulli A, Regge D, Veronese S, Comoglio PM, Bardelli A, Marsoni S, Siena S. Sartore-Bianchi A, et al. Lancet Oncol. 2016 Jun;17(6):738-746. doi: 10.1016/S1470-2045(16)00150-9. Epub 2016 Apr 20. Lancet Oncol. 2016. PMID: 27108243 Free article. Clinical Trial.
Stromal contribution to the colorectal cancer transcriptome.
Isella C, Terrasi A, Bellomo SE, Petti C, Galatola G, Muratore A, Mellano A, Senetta R, Cassenti A, Sonetto C, Inghirami G, Trusolino L, Fekete Z, De Ridder M, Cassoni P, Storme G, Bertotti A, Medico E. Isella C, et al. Nat Genet. 2015 Apr;47(4):312-9. doi: 10.1038/ng.3224. Epub 2015 Feb 23. Nat Genet. 2015. PMID: 25706627 Free article.
Tumor Evolution as a Therapeutic Target.
Amirouchene-Angelozzi N, Swanton C, Bardelli A. Amirouchene-Angelozzi N, et al. Cancer Discov. 2017 Jul 20. doi: 10.1158/2159-8290.CD-17-0343. Online ahead of print. Cancer Discov. 2017. PMID: 28729406 Free article. Review.
1,557 results
Jump to page